Key Takeaways Hologic's Diagnostics faces pressure from China's challenges and reduced HIV testing funding in Africa.Hologic's International Surgical increased about 25% in Q3 2025, with NovaSure thriving overseas.HOLX's Panther platform hits record use; Genius digital diagnostics expands globally with strong feedback. Expanding internationally is a key part of Hologic’s (HOLX) growth strategy, though it isn’t immune to the macroeconomic risks that come with it. The company’s Diagnostics segment outside the ...